메뉴 건너뛰기




Volumn 72, Issue 2, 2013, Pages 429-435

Phase II study of single agent oral vinorelbine as first-line treatment in patients with HER-2 negative metastatic breast cancer

Author keywords

Advanced breast cancer; Oral chemotherapy; Oral vinorelbine; Single agent

Indexed keywords

ANTHRACYCLINE DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR; NAVELBINE; TAXANE DERIVATIVE;

EID: 84880924325     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-013-2216-8     Document Type: Article
Times cited : (9)

References (36)
  • 1
    • 0037152667 scopus 로고    scopus 로고
    • Oral cancer treatment: Developments in chemotherapy and beyond
    • DOI 10.1038/sj.bjc.6600591
    • O'Neill VJ, Twelves CJ (2002) Oral cancer treatment: developments in chemotherapy and beyond. Br J Cancer 87(9):933-937. doi: 10.1038/sj.bjc.6600591 (Pubitemid 35305640)
    • (2002) British Journal of Cancer , vol.87 , Issue.9 , pp. 933-937
    • O'Neill, V.J.1    Twelves, C.J.2
  • 2
    • 38849106122 scopus 로고    scopus 로고
    • Effective oral chemotherapy for breast cancer: Pill ars of strength
    • DOI 10.1093/annonc/mdm285
    • Findlay M, von Minckwitz G, Wardley A (2008) Effective oral chemotherapy for breast cancer: pillars of strength. Ann Oncol 19(2):212-222. doi: 10.1093/annonc/mdm285 (Pubitemid 351201700)
    • (2008) Annals of Oncology , vol.19 , Issue.2 , pp. 212-222
    • Findlay, M.1    Von Minckwitz, G.2    Wardley, A.3
  • 3
    • 0031017851 scopus 로고    scopus 로고
    • Patient preferences for oral versus intravenous palliative chemotherapy
    • Liu G, Franssen E, Fitch MI, Warner E (1997) Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 15(1):110-115 (Pubitemid 27021524)
    • (1997) Journal of Clinical Oncology , vol.15 , Issue.1 , pp. 110-115
    • Liu, G.1    Franssen, E.2    Fitch, M.I.3    Warner, E.4
  • 4
    • 24944449437 scopus 로고    scopus 로고
    • Modulation of oral drug bioavailability: From preclinical mechanism to therapeutic application
    • DOI 10.1081/CNV-58823
    • Kuppens IE, Breedveld P, Beijnen JH, Schellens JH (2005) Modulation of oral drug bioavailability: from preclinical mechanism to therapeutic application. Cancer Invest 23(5):443-464 (Pubitemid 41324362)
    • (2005) Cancer Investigation , vol.23 , Issue.5 , pp. 443-464
    • Kuppens, I.E.L.M.1    Breedveld, P.2    Beijnen, J.H.3    Schellens, J.H.M.4
  • 6
    • 34047202064 scopus 로고    scopus 로고
    • Oral vinorelbine: Role in the management of metastatic breast cancer
    • DOI 10.2165/00003495-200767050-00002
    • Aapro MS, Conte P, Esteban Gonzalez E, Trillet-Lenoir V (2007) Oral vinorelbine: role in the management of metastatic breast cancer. Drugs 67(5):657-667 (Pubitemid 46535641)
    • (2007) Drugs , vol.67 , Issue.5 , pp. 657-667
    • Aapro, M.S.1    Conte, P.2    Gonzalez, E.E.3    Trillet-Lenoir, V.4
  • 8
    • 24644482057 scopus 로고    scopus 로고
    • Perception that oral anticancer treatments are less efficacious: Development of a questionnaire to assess the possible prejudices of patients with cancer
    • DOI 10.1007/s10549-005-3376-y
    • Catania C, Didier F, Leon ME, Sbanotto A, Mariani L, Nole F, Leida E, Rocca A, De Pas T, Goldhirsch A (2005) Perception that oral anticancer treatments are less efficacious: development of a questionnaire to assess the possible prejudices of patients with cancer. Breast Cancer Res Treat 92(3):265-272. doi: 10.1007/s10549-005-3376-y (Pubitemid 41279636)
    • (2005) Breast Cancer Research and Treatment , vol.92 , Issue.3 , pp. 265-272
    • Catania, C.1    Didier, F.2    Leon, M.E.3    Sbanotto, A.4    Mariani, L.5    Nole, F.6    Leida, E.7    Rocca, A.8    De Pas, T.9    Goldhirsch, A.10
  • 9
    • 34247553690 scopus 로고    scopus 로고
    • Overview of the changing paradigm in cancer treatment: Oral chemotherapy
    • DOI 10.2146/ajhp070035
    • Aisner J (2007) Overview of the changing paradigm in cancer treatment: oral chemotherapy. Am J Health Syst Pharm 64(9 Suppl 5):S4-S7. doi: 10.2146/ajhp070035 (Pubitemid 46676685)
    • (2007) American Journal of Health-System Pharmacy , vol.64 , Issue.9 SUPPL.
    • Aisner, J.1
  • 10
    • 14944385553 scopus 로고    scopus 로고
    • Pisani P (2005) Global cancer statistics
    • 10.3322/canjclin.55.2.74
    • Parkin DM, Bray F, Ferlay J (2002) Pisani P (2005) Global cancer statistics. CA Cancer J Clin 55(2):74-108
    • (2002) CA Cancer J Clin , vol.55 , Issue.2 , pp. 74-108
    • Parkin, D.M.1    Bray, F.2    Ferlay, J.3
  • 11
    • 31444447160 scopus 로고    scopus 로고
    • Extending survival with chemotherapy in metastatic breast cancer
    • DOI 10.1634/theoncologist.10-90003-20
    • O'Shaughnessy J (2005) Extending survival with chemotherapy in metastatic breast cancer. Oncologist 10(Suppl 3):20-29. doi: 10.1634/theoncologist.10- 90003-20 (Pubitemid 43152727)
    • (2005) Oncologist , vol.10 , Issue.SUPPL. 3 , pp. 20-29
    • O'Shaughnessy, J.1
  • 12
    • 0035049886 scopus 로고    scopus 로고
    • Chemotherapy of metastatic breast cancer: What to expect in 2001 and beyond
    • DOI 10.1634/theoncologist.6-2-133
    • Esteva FJ, Valero V, Pusztai L, Boehnke-Michaud L, Buzdar AU, Hortobagyi GN (2001) Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond. Oncologist 6(2):133-146 (Pubitemid 32323452)
    • (2001) Oncologist , vol.6 , Issue.2 , pp. 133-146
    • Esteva, F.J.1    Valero, V.2    Pusztai, L.3    Boehnke-Michaud, L.4    Buzdar, A.U.5    Hortobagyi, G.N.6
  • 13
    • 46949103546 scopus 로고    scopus 로고
    • Metastatic breast cancer: The treatment challenge
    • DOI 10.3816/CBC.2008.n.025
    • Jones SE (2008) Metastatic breast cancer: the treatment challenge. Clin Breast Cancer 8(3):224-233. doi: 10.3816/CBC.2008.n.025 (Pubitemid 351962143)
    • (2008) Clinical Breast Cancer , vol.8 , Issue.3 , pp. 224-233
    • Jones, S.E.1
  • 14
    • 33846436108 scopus 로고    scopus 로고
    • Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program
    • DOI 10.1634/theoncologist.12-1-20
    • Hayat MJ, Howlader N, Reichman ME, Edwards BK (2007) Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12(1):20-37. doi: 10.1634/theoncologist.12-1-20 (Pubitemid 46143500)
    • (2007) Oncologist , vol.12 , Issue.1 , pp. 20-37
    • Hayat, M.J.1    Howlader, N.2    Reichman, M.E.3    Edwards, B.K.4
  • 15
    • 77956333064 scopus 로고    scopus 로고
    • Algorithms for the treatment of patients with metastatic breast cancer and prior exposure to taxanes and anthracyclines
    • 10.3816/CBC.2010.s.008 20805067 10.3816/CBC.2010.s.008 1:CAS:528:DC%2BC3cXht1Whu7nP
    • Comen EA, Fornier MN (2010) Algorithms for the treatment of patients with metastatic breast cancer and prior exposure to taxanes and anthracyclines. Clin Breast Cancer 10(Suppl 2):S7-19. doi: 10.3816/CBC.2010.s.008
    • (2010) Clin Breast Cancer , vol.10 , Issue.SUPPL. 2 , pp. 7-19
    • Comen, E.A.1    Fornier, M.N.2
  • 17
    • 26444607816 scopus 로고    scopus 로고
    • Survival of metastatic breast carcinoma patients over a 20-year period: A retrospective analysis based on individual patient data from six consecutive studies
    • DOI 10.1002/cncr.21359
    • Gennari A, Conte P, Rosso R, Orlandini C, Bruzzi P (2005) Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies. Cancer 104(8):1742-1750. doi: 10.1002/cncr.21359 (Pubitemid 41437440)
    • (2005) Cancer , vol.104 , Issue.8 , pp. 1742-1750
    • Gennari, A.1    Conte, P.2    Rosso, R.3    Orlandini, C.4    Bruzzi, P.5
  • 18
    • 34548187711 scopus 로고    scopus 로고
    • The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer
    • DOI 10.1002/cncr.22867
    • Chia SK, Speers CH, D'Yachkova Y, Kang A, Malfair-Taylor S, Barnett J, Coldman A, Gelmon KA, O'Reilly SE, Olivotto IA (2007) The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer 110(5):973-979. doi: 10.1002/cncr.22867 (Pubitemid 47312861)
    • (2007) Cancer , vol.110 , Issue.5 , pp. 973-979
    • Chia, S.K.1    Speers, C.H.2    D'Yachkova, Y.3    Kang, A.4    Malfair-Taylor, S.5    Barnett, J.6    Coldman, A.7    Gelmon, K.A.8    O'Reilly, S.E.9    Olivotto, I.A.10
  • 19
    • 0034079089 scopus 로고    scopus 로고
    • Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer
    • DOI 10.1053/ctrv.1999.0161
    • Stockler M, Wilcken NR, Ghersi D, Simes RJ (2000) Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. Cancer Treat Rev 26(3):151-168. doi: 10.1053/ctrv.1999.0161 (Pubitemid 30330662)
    • (2000) Cancer Treatment Reviews , vol.26 , Issue.3 , pp. 151-168
    • Stockler, M.1    Wilcken, N.R.C.2    Ghersi, D.3    Simes, R.J.4
  • 20
    • 79952087724 scopus 로고    scopus 로고
    • How long have i got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: A systematic review of recent randomized trials
    • 10.1200/JCO.2010.30.2174 21189397 10.1200/JCO.2010.30.2174
    • Kiely BE, Soon YY, Tattersall MH, Stockler MR (2011) How long have I got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: a systematic review of recent randomized trials. J Clin Oncol 29(4):456-463. doi: 10.1200/JCO.2010.30. 2174
    • (2011) J Clin Oncol , vol.29 , Issue.4 , pp. 456-463
    • Kiely, B.E.1    Soon, Y.Y.2    Tattersall, M.H.3    Stockler, M.R.4
  • 21
    • 70349260426 scopus 로고    scopus 로고
    • Single agent versus combination chemotherapy for metastatic breast cancer
    • 10.1002/14651858.CD003372.pub3 19370586
    • Carrick S, Parker S, Thornton CE, Ghersi D, Simes J, Wilcken N (2009) Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database Syst Rev 2:CD003372. doi: 10.1002/14651858.CD003372.pub3
    • (2009) Cochrane Database Syst Rev , vol.2 , pp. 003372
    • Carrick, S.1    Parker, S.2    Thornton, C.E.3    Ghersi, D.4    Simes, J.5    Wilcken, N.6
  • 23
    • 84866597106 scopus 로고    scopus 로고
    • Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    • 10.1093/annonc/mds232 22997442 10.1093/annonc/mds232
    • Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E (2012) Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii11-vii19. doi: 10.1093/annonc/mds232
    • (2012) Ann Oncol , vol.23 , Issue.SUPPL. 7
    • Cardoso, F.1    Harbeck, N.2    Fallowfield, L.3    Kyriakides, S.4    Senkus, E.5
  • 24
    • 84856031837 scopus 로고    scopus 로고
    • Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: Joint analysis of 2 consecutive prospective phase II trials
    • 10.1016/j.clbc.2011.11.001 22154360 10.1016/j.clbc.2011.11.001 1:CAS:528:DC%2BC38Xht1OnsLY%3D
    • Strada MR, Palumbo R, Bernardo A, Riccardi A, Teragni C, Poggi G, Frascaroli M, Amatu A, Montagna B, Sottotetti F, Tagliaferri B, Bernardo G (2012) Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials. Clin Breast Cancer 12(1):30-39. doi: 10.1016/j.clbc.2011.11.001
    • (2012) Clin Breast Cancer , vol.12 , Issue.1 , pp. 30-39
    • Strada, M.R.1    Palumbo, R.2    Bernardo, A.3    Riccardi, A.4    Teragni, C.5    Poggi, G.6    Frascaroli, M.7    Amatu, A.8    Montagna, B.9    Sottotetti, F.10    Tagliaferri, B.11    Bernardo, G.12
  • 27
    • 41549104608 scopus 로고    scopus 로고
    • Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: Findings from the EORTC 10001 randomized phase II trial
    • DOI 10.1016/j.breast.2007.09.002, PII S0960977607001932
    • Pajk B, Cufer T, Canney P, Ellis P, Cameron D, Blot E, Vermorken J, Coleman R, Marreaud S, Bogaerts J, Basaran G, Piccart M (2008) Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from the EORTC 10001 randomized phase II trial. Breast 17(2):180-185. doi: 10.1016/j.breast.2007.09. 002 (Pubitemid 351467955)
    • (2008) Breast , vol.17 , Issue.2 , pp. 180-185
    • Pajk, B.1    Cufer, T.2    Canney, P.3    Ellis, P.4    Cameron, D.5    Blot, E.6    Vermorken, J.7    Coleman, R.8    Marreaud, S.9    Bogaerts, J.10    Basaran, G.11    Piccart, M.12
  • 32
    • 0032776863 scopus 로고    scopus 로고
    • Locally advanced breast cancer in Saudi Arabia: High frequency of stage III in a young population
    • Ezzat AA, Ibrahim EM, Raja MA, Al-Sobhi S, Rostom A, Stuart RK (1999) Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population. Med Oncol 16(2):95-103 (Pubitemid 29349855)
    • (1999) Medical Oncology , vol.16 , Issue.2 , pp. 95-103
    • Ezzat, A.A.1    Ibrahim, E.M.2    Raja, M.A.3    Al-Sobhi, S.4    Rostom, A.5    Stuart, R.K.6
  • 34
    • 84867776380 scopus 로고    scopus 로고
    • Final results of an international retrospective observational study in patients with advanced breast cancer treated with oral vinorelbine-based chemotherapy
    • 23060583 1:CAS:528:DC%2BC38Xhs1ygtbfO
    • Palomo AG, Glogowska I, Sommer H, Malamos N, Kilar E, Vega JM, Torrecillas L, Delozier T, Ettl J, Finek J (2012) Final results of an international retrospective observational study in patients with advanced breast cancer treated with oral vinorelbine-based chemotherapy. Anticancer Res 32(10):4539-4545
    • (2012) Anticancer Res , vol.32 , Issue.10 , pp. 4539-4545
    • Palomo, A.G.1    Glogowska, I.2    Sommer, H.3    Malamos, N.4    Kilar, E.5    Vega, J.M.6    Torrecillas, L.7    Delozier, T.8    Ettl, J.9    Finek, J.10
  • 36
    • 84878765775 scopus 로고    scopus 로고
    • Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer
    • 10.1007/s10549-012-2288-x 23104222 10.1007/s10549-012-2288-x 1:CAS:528:DC%2BC38XhslyltbnI
    • Blum JL, Barrios CH, Feldman N, Verma S, McKenna EF, Lee LF, Scotto N, Gralow J (2012) Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer. Breast Cancer Res Treat 136(3):777-788. doi: 10.1007/s10549-012-2288-x
    • (2012) Breast Cancer Res Treat , vol.136 , Issue.3 , pp. 777-788
    • Blum, J.L.1    Barrios, C.H.2    Feldman, N.3    Verma, S.4    McKenna, E.F.5    Lee, L.F.6    Scotto, N.7    Gralow, J.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.